Last reviewed · How we verify
PRF110
At a glance
| Generic name | PRF110 |
|---|---|
| Also known as | Ropivacaine oily solution |
| Sponsor | PainReform LTD |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate Analgesic Efficacy and Safety of PRF-110 for Post-surgical Pain (PHASE3)
- A Single-dose Open-Label Study to Assess the Safety and Preliminary Efficacy of PRF 110 in Open Herniorrhaphy Surgery (PHASE2)
- A Safety and Effectiveness Pilot Study of PRF-108 and PRF-110 in Healthy Volunteers (PHASE1, PHASE2)
- A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of PRF110 in Bunionectomy Surgery (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PRF110 CI brief — competitive landscape report
- PRF110 updates RSS · CI watch RSS
- PainReform LTD portfolio CI